e-learning
resources
Barcelona 2010
Tuesday, 21.09.2010
Paediatric respiratory epidemiology: early origins of childhood asthma
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Asthma medication and antibiotics – Cause or effect?
C. Lundholm, B. Wettermark, C. Almqvist (Stockholm, Sweden)
Source:
Annual Congress 2010 - Paediatric respiratory epidemiology: early origins of childhood asthma
Session:
Paediatric respiratory epidemiology: early origins of childhood asthma
Session type:
E-Communication Session
Number:
3786
Disease area:
Paediatric lung diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Lundholm, B. Wettermark, C. Almqvist (Stockholm, Sweden). Asthma medication and antibiotics – Cause or effect?. Eur Respir J 2010; 36: Suppl. 54, 3786
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Asthma in elderly – What is the difference?
Source: Annual Congress 2012 - Distinguishing phenotypes and dealing with comorbidities in primary care
Year: 2012
Oral glucocorticoid treatment of severe asthma – Current practice in the US
Source: Annual Congress 2010 - Aspects of severe asthma
Year: 2010
Documentation & accuracy of smoking status – An educational need?
Source: Annual Congress 2011 - Smoking cessation science and smoking-related disorders
Year: 2011
Risk for adverse outcomes in asthma: Assess to impress!
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016
Smoking assessment & treatment in hospital: Are we providing ‘right care‘ and/or missing cannabis-smoking?
Source: Annual Congress 2011 - Anti-smoking interventions: prevention and treatment
Year: 2011
Adherence with inhaled corticosteroids in asthma: Does pregnancy lead to improved adherence?
Source: International Congress 2014 – Asthma: still a heterogeneous condition!
Year: 2014
Use of non-steroid antiinflammatory therapy in COPD patients – Clinical effectiveness and influence on the physical tolerance
Source: Annual Congress 2010 - COPD: management
Year: 2010
Chronic dosing effects of propranolol in asthma
Source: Annual Congress 2013 –Asthma and COPD management: novel clinical findings
Year: 2013
Cryptogenic organising pneumonia – clarithromycin treatment – factors influencing treatment results and relapses
Source: Annual Congress 2009 - Various backgrounds in diffuse parenchymal lung disease
Year: 2009
Treatment of sarcoidosis – pentoxifylline
Source: Annual Congress 2009 - Pleural and parenchymal diseases
Year: 2009
Long term inhalatory therapy in asthma – Achieving control of the disease
Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management
Year: 2012
Hemoptysis: Causes, interventions and outcomes – Indian single centre experience
Source: Annual Congress 2012 - New insights in the clinical management of lung diseases
Year: 2012
Asthma control test – Suitable for children from 4 to 11 years?
Source: Annual Congress 2010 - Quality of life, asthma control and monitoring childhood asthma
Year: 2010
Asthma control – Psychosomatic correlation and mental disorders
Source: Annual Congress 2010 - Questionnaires use and psychological aspects in asthma
Year: 2010
Tuberculosis – is there anything different over a decade?
Source: Annual Congress 2009 - Socio-economic impact of tuberculosis
Year: 2009
Late Breaking Abstract: Inhalation technique errors and education effects in the group of patients using Aerolizer® – The real life study
Source: Annual Congress 2010 - Medical education: methodology
Year: 2010
Evaluation of difficult asthma – a single centre experience
Source: Annual Congress 2009 - Towards improving asthma control
Year: 2009
Triple 0 – A new respiratory syndrome?
Source: Annual Congress 2012 - Advanced experience with long-term noninvasive ventilation and late-breaking abstracts
Year: 2012
Comorbidity by smokers – A cumulative effect of exogenic and endogenic factors?
Source: Annual Congress 2012 - Tobacco comorbidity
Year: 2012
Drug interaction in tuberculosis treatment – The role of pharmacists
Source: Annual Congress 2012 - Tuberculosis: clinical findings II
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept